Showing results (121-130 of 177) with videos related to
Sort By:
Pageof 18
Journal of Clinical Medicine|April 12, 2022
New Analytical Approach for the Alignment of Different HE4 Automated Immunometric Systems: An Italian Multicentric StudyAntonio Angeloni, Corrado De Vito, Antonella Farina, et al.Critical Reviews in Oncology/Hematology|June 1, 2020
Predictors of efficacy of androgen-receptor-axis-targeted therapies in patients with metastatic castration-sensitive prostate cancer: A systematic review and meta-analysisCarlo Buonerba, Matteo Ferro, Pasquale Dolce, et al.Journal of Translational Medicine|July 4, 2013
Cytosolic phosphorylated EGFR is predictive of recurrence in early stage penile cancer patients: a retropective studyGiuseppe Di Lorenzo, Sisto Perdonà, Carlo Buonerba, et al.Reproductive Biology|September 4, 2024
Preliminary study on the role of human defensins, interleukins and PCSK9 in early and late preeclampsiaCristina Mennitti, Laura Sarno, Mariella Calvanese, et al.Biomolecules|November 27, 2024
How Does Physical Activity Modulate Hormone Responses?Cristina Mennitti, Gabriele Farina, Antonio Imperatore, et al.International Journal of Environmental Research and Public Health|February 15, 2022
The Biological Role of Vitamins in Athletes' Muscle, Heart and MicrobiotaMariarita Brancaccio, Cristina Mennitti, Arturo Cesaro, et al.Future Oncology (London, England)|September 15, 2016
The emerging role of obesity, diet and lipid metabolism in prostate cancerMatteo Ferro, Daniela Terracciano, Carlo Buonerba, et al.International Journal of Molecular Sciences|September 28, 2021
Prostate Cancer Radiogenomics-From Imaging to Molecular CharacterizationMatteo Ferro, Ottavio de Cobelli, Mihai Dorin Vartolomei, et al.Aging|March 14, 2020
Surgical blood loss during holmium laser enucleation of the prostate (HoLEP) is not affected by short-term pretreatment with dutasteride: a double-blind placebo-controlled trial on prostate vascularityGian Maria Busetto, Francesco Del Giudice, Martina Maggi, et al.Urologia Internationalis|June 10, 2020
SARS-CoV-2 Infection and High-Risk Non-Muscle-Invasive Bladder Cancer: Are There Any Common Features?Gian Maria Busetto, Angelo Porreca, Francesco Del Giudice, et al.Pageof 18